Le Lézard
Classified in: Health
Subject: PER

Meadows Behavioral Healthcare Announces Deal With New York Times Bestselling Author Resmaa Menakem


WICKENBURG, Ariz., Jan. 12, 2021 /PRNewswire/ -- Meadows Behavioral Healthcare has finalized an agreement with bestselling author, visionary justice leadership coach, organizational strategist, and master trainer Resmaa Menakem to join their team as a Meadows Senior Fellow.

Resmaa Menakem brings his expertise and leading voice on racialized trauma to The Meadows' proven treatment programs.

Meadows Senior Fellows are some of the nation's top addiction and recovery experts, and they provide ongoing direction, consultation, and training for staff as well as interacting with patients. Led by Pia Mellody, they work together to ensure that The Meadows Model is the most clinically comprehensive and nurturing program available today. Meadows Behavioral Healthcare's network of specialized behavioral healthcare programs provide evidence-based treatment for those struggling with emotional trauma, drug and alcohol addiction, sex addiction, eating disorders, psychiatric disorders, and co-occurring conditions.

Menakem is a natural fit to join the work Meadows Behavioral Healthcare is already doing. An expert on the topics of race and trauma, he is the author of the New York Times bestseller My Grandmother's Hands: Racialized Trauma and the Pathway to Mending Our Hearts and Bodies. Mentored by the late clinical psychologist Dr. David Schnarch for 20 years, Menakem has built a worldwide reputation as a leading voice in today's conversation on racialized trauma and is currently working with notable organizations including the NFL and several major police departments and cities.

"This focus on racialized trauma sadly is long overdue in the industry, and we are excited about how Resmaa will enhance the amazing work already happening in our treatment programs," says Sean Walsh, CEO of Meadows Behavioral Healthcare. "Our longstanding focus on addressing emotional trauma is already in line with the work Resmaa is currently doing. Further enhancing our clinical teams' expertise and our overall company culture on racialized trauma will help us ensure both our MBH team and the clients we are entrusted to serve get the care they deserve."

Plans are already underway to incorporate Menakem's work into Meadows curriculum and modalities, and leadership is working with him to develop a workshop to help train clinicians on how to better treat racialized trauma.

"Part of what I've been trying to help people do is to begin to develop with other bodies what I call a living embodied and anti-racist culture and practices so those things that could emerge as healing have a place to sprout up from," Menakem explains. "I'm so excited about this opportunity to work with The Meadows to help further this work of healing racialized trauma."

For more information on Resmaa Menakem, visit resmaa.com.

Read the full release on our website. For more information on Meadows Behavioral Healthcare, visit meadowsbh.com.

 

SOURCE Meadows Behavioral Healthcare


These press releases may also interest you

at 16:32
The wishes that Make-A-Wish grants wouldn't be possible without the support of countless "WishMakers" such as donors, volunteers, corporate partners, community advocates and more. "WishMakers" ? a term for anyone who steps up to take action...

at 16:30
Today, the Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, announced a new appointment to the Canadian Centre on Substance Use and Addiction (CCSA) Board of Directors. Scott Elliott is appointed as...

at 16:28
The Rett Syndrome Research Trust (RSRT) is proud to announce its partnership with PMD Solutions, a leading provider of innovative healthcare technologies, in their upcoming biosensor validation study called VIBRANT. PMD Solutions will generously...

at 16:20
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced business updates and financial results for the fourth quarter and full year ended December 31,...

at 16:20
AN2 Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today reported financial results for the fourth quarter and year ended...

at 16:20
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that its Board of Directors has unanimously approved plans to initiate a rights offering. The...



News published on and distributed by: